
Mary M. Lyons
Examiner (ID: 1163, Phone: (571)272-2966 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1653, 1645 |
| Total Applications | 662 |
| Issued Applications | 371 |
| Pending Applications | 93 |
| Abandoned Applications | 224 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18109411
[patent_doc_number] => 20230002291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => Natural Organic Nano-Fertilizers and Their Process of Production
[patent_app_type] => utility
[patent_app_number] => 17/779325
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779325
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779325 | Natural Organic Nano-Fertilizers and Their Process of Production | Jul 7, 2020 | Pending |
Array
(
[id] => 17664169
[patent_doc_number] => 11357845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Protein antigens for vaccinating against nontypeable
[patent_app_type] => utility
[patent_app_number] => 16/922463
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 36
[patent_no_of_words] => 15102
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922463
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/922463 | Protein antigens for vaccinating against nontypeable | Jul 6, 2020 | Issued |
Array
(
[id] => 18560854
[patent_doc_number] => 11726094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Methods for determining DPP3 and therapeutic methods
[patent_app_type] => utility
[patent_app_number] => 16/919449
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 29
[patent_no_of_words] => 23509
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919449
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919449 | Methods for determining DPP3 and therapeutic methods | Jul 1, 2020 | Issued |
Array
(
[id] => 16389623
[patent_doc_number] => 20200330564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => METHOD TO MANUFACTURE A STABLE PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/918769
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918769
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/918769 | METHOD TO MANUFACTURE A STABLE PROTEIN | Jun 30, 2020 | Abandoned |
Array
(
[id] => 16389627
[patent_doc_number] => 20200330568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/918248
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/918248 | NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES | Jun 30, 2020 | Abandoned |
Array
(
[id] => 17830479
[patent_doc_number] => 20220267783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => FILAMENTOUS FUNGAL EXPRESSION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/630107
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630107
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630107 | FILAMENTOUS FUNGAL EXPRESSION SYSTEM | Jun 24, 2020 | Abandoned |
Array
(
[id] => 17733353
[patent_doc_number] => 20220218812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => METHODS OF TREATING PATIENTS WITH AN IMMUNOGENIC COMPOSITION THAT PROTECTS AGAINST S. PNEUMONIAE SEROTYPE 29
[patent_app_type] => utility
[patent_app_number] => 17/614876
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614876 | METHODS OF TREATING PATIENTS WITH AN IMMUNOGENIC COMPOSITION THAT PROTECTS AGAINST S. PNEUMONIAE SEROTYPE 29 | May 31, 2020 | Abandoned |
Array
(
[id] => 16310820
[patent_doc_number] => 20200289558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS
[patent_app_type] => utility
[patent_app_number] => 16/888407
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888407 | AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS | May 28, 2020 | Abandoned |
Array
(
[id] => 17362683
[patent_doc_number] => 11229691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => Vaccine composition against
[patent_app_type] => utility
[patent_app_number] => 16/884649
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 11
[patent_no_of_words] => 10828
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884649
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884649 | Vaccine composition against | May 26, 2020 | Issued |
Array
(
[id] => 19947098
[patent_doc_number] => 12318436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Composition and method for spray drying an adjuvant vaccine emulsion
[patent_app_type] => utility
[patent_app_number] => 17/612893
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23079
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612893
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612893 | Composition and method for spray drying an adjuvant vaccine emulsion | May 25, 2020 | Issued |
Array
(
[id] => 16755380
[patent_doc_number] => 10973908
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-04-13
[patent_title] => Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
[patent_app_type] => utility
[patent_app_number] => 15/931669
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 29810
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931669
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931669 | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine | May 13, 2020 | Issued |
Array
(
[id] => 16328769
[patent_doc_number] => 20200299735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => METABOLIC ENGINEERING FOR MICROBIAL PRODUCTION OF TERPENOID PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 16/862209
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862209
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862209 | Metabolic engineering for microbial production of terpenoid products | Apr 28, 2020 | Issued |
Array
(
[id] => 16326816
[patent_doc_number] => 20200297781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => Composition, A Treatment Method and An Application Thereof
[patent_app_type] => utility
[patent_app_number] => 16/841949
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841949
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/841949 | Composition, A Treatment Method and An Application Thereof | Apr 6, 2020 | Abandoned |
Array
(
[id] => 17526847
[patent_doc_number] => 11299519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Host cells and methods using a repressor polypeptide and an inducible promoter for gene expression
[patent_app_type] => utility
[patent_app_number] => 16/831649
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 23
[patent_no_of_words] => 6240
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831649
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/831649 | Host cells and methods using a repressor polypeptide and an inducible promoter for gene expression | Mar 25, 2020 | Issued |
Array
(
[id] => 18384722
[patent_doc_number] => 11655494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Apparatus, systems, and methods for determining the concentration of microorganisms and the susceptibility of microorganisms to anti-infectives based on redox reactions
[patent_app_type] => utility
[patent_app_number] => 16/814153
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 19689
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814153 | Apparatus, systems, and methods for determining the concentration of microorganisms and the susceptibility of microorganisms to anti-infectives based on redox reactions | Mar 9, 2020 | Issued |
Array
(
[id] => 17097213
[patent_doc_number] => 20210285004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => Bidirectional Constitutive Promoter and Uses, and Transfection Methods for B. Microti
[patent_app_type] => utility
[patent_app_number] => 16/813940
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813940 | Bidirectional Constitutive Promoter and Uses, and Transfection Methods for B. Microti | Mar 9, 2020 | Abandoned |
Array
(
[id] => 16086457
[patent_doc_number] => 20200197215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => Method and System for Reducing the Likelihood of a Porphyromonas Gingivalis Infection in a Human Being
[patent_app_type] => utility
[patent_app_number] => 16/804361
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804361
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/804361 | Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being | Feb 27, 2020 | Issued |
Array
(
[id] => 16223074
[patent_doc_number] => 20200248190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => BIOSYNTHETIC AMYLOID-BASED MATERIALS DISPLAYING FUNCTIONAL PROTEIN SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 16/785874
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785874
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785874 | Biosynthetic amyloid-based materials displaying functional protein sequences | Feb 9, 2020 | Issued |
Array
(
[id] => 16482445
[patent_doc_number] => 20200376045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => PROBIOTIC BACTERIA FOR THE TOPICAL TREATMENT OF SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/786079
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16786079
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/786079 | PROBIOTIC BACTERIA FOR THE TOPICAL TREATMENT OF SKIN DISORDERS | Feb 9, 2020 | Abandoned |
Array
(
[id] => 15931053
[patent_doc_number] => 20200157160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/777154
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16777154
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/777154 | Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof | Jan 29, 2020 | Issued |